Translational phase I study with biomarker-defined end points. Phase I... | Download Scientific Diagram
Phase I study design with dose-escalation and dose-expansion phases | Download Scientific Diagram
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results | Nature Medicine
Dose–response relationship - Wikipedia
Zero-dose children and missed communities
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - ScienceDirect
Vaccines | Free Full-Text | Why Reaching Zero-Dose Children Holds the Key to Achieving the Sustainable Development Goals
Genetic Code Expansion: A Brief History and Perspective | Biochemistry
Definition of the dose change intervals and construction of features.... | Download Scientific Diagram
Study design. a Framework for the dose-escalation and dose-expansion... | Download Scientific Diagram
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
The natural history of canine occult Grade II medial patellar luxation: an observational study
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
EX-99.2
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - ScienceDirect
Traditional sequential phase versus seamless expansion trial design. a... | Download Scientific Diagram
Phase I trials - memoinOncology
Frontiers | Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation
How to Find and Participate in a GIST clinical trial - ppt download
Final SAP
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - ScienceDirect
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician | JCO Precision Oncology
Bertrand Delsuc on X: "@BiotechRadar CUARt123 AML: RP2D definition, extensive DLT recording (differences vs ALL), dose expansion, risks assessment https://t.co/aDIcKjyNon" / X
Alex A. Adjei, MD, PhD Designing Phase I Trials with Targeted Agents: Challenging Tradition. - ppt download
Phase 1 clinical trials: Designs and considerations
